Remdesivir
Remdesivir
Class of drug: Broad spectrum anti coronavirus
Mechanism: it blocks the enzymes (RNA polymerase) needed by coronavirus to make its copies decreasing the viral load
Current status: Experimental
Indications: COVID-19 suspected or confirmed – requiring oxygen, mechanical ventilation or ECMO
Dose:
Intravenous- 200 mg on day 1 then 100 mg OD for total 5 days- if not on mechanical ventilation
Duration 10 days if on mechanical ventilation
Not recommended in severe renal failure
Side Effects- Anaemia, nephrotoxicity, hepatotoxicity, Nausea, vomiting etc.
FDA Status: Remdesivir is not an approved drug for SARS Cov-2 or any other infection. FDA has approved EUA (Emergency Use Authorisation) of Remdesivir for the hospitalised patients
Bottom line: Remdesivir can be a drug to be tried in correct clinical setting
Source: Drugs.com
===========
Dr. Prashant Kumar
Comments
Post a Comment
Thanks for your comments, will reply you soon!!!